These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19925576)
1. Calcium and phosphorus homeostasis in dogs with spontaneous chronic kidney disease at different stages of severity. Cortadellas O; Fernández del Palacio MJ; Talavera J; Bayón A J Vet Intern Med; 2010; 24(1):73-9. PubMed ID: 19925576 [TBL] [Abstract][Full Text] [Related]
2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease. Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560 [TBL] [Abstract][Full Text] [Related]
4. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease. Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657 [TBL] [Abstract][Full Text] [Related]
6. Urinary Fractional Excretion of Phosphorus in Dogs with Spontaneous Chronic Kidney Disease. Martorelli CR; Kogika MM; Chacar FC; Caragelasco DS; de Campos Fonseca Pinto ACB; Lorigados CAB; Andrade LC Vet Sci; 2017 Dec; 4(4):. PubMed ID: 29240673 [TBL] [Abstract][Full Text] [Related]
7. Renal handling of calcium and phosphorus in experimental renal hyperparathyroidism in dogs. García-Rodríguez MB; Pérez-García CC; Ríos-Granja MA; Cano-Rábano MJ; Peña-Penabad M; Gallego-Morales D; García-Partida P; Diez-Prieto I Vet Res; 2003; 34(4):379-87. PubMed ID: 12911855 [TBL] [Abstract][Full Text] [Related]
8. Prognostic role of the product of serum calcium and phosphorus concentrations in dogs with chronic kidney disease: 31 cases (2008-2010). Lippi I; Guidi G; Marchetti V; Tognetti R; Meucci V J Am Vet Med Assoc; 2014 Nov; 245(10):1135-40. PubMed ID: 25356714 [TBL] [Abstract][Full Text] [Related]
9. Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease. Parker VJ; Rudinsky AJ; Benedict JA; Beizaei A; Chew DJ J Vet Intern Med; 2020 Nov; 34(6):2497-2506. PubMed ID: 33128421 [TBL] [Abstract][Full Text] [Related]
10. Glomerular filtration rate in dogs with leishmaniasis and chronic kidney disease. Cortadellas O; Fernández del Palacio MJ; Talavera J; Bayón A J Vet Intern Med; 2008; 22(2):293-300. PubMed ID: 18371023 [TBL] [Abstract][Full Text] [Related]
11. Serum phosphorus concentrations in dogs with leishmaniosis at different stages of chronic kidney disease. Cortadellas O; Fernández-del Palacio MJ; Talavera J; Bayón A Vet Rec; 2009 Apr; 164(16):487-90. PubMed ID: 19377087 [TBL] [Abstract][Full Text] [Related]
12. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Winkelmayer WC; Levin R; Avorn J Kidney Int; 2003 May; 63(5):1836-42. PubMed ID: 12675861 [TBL] [Abstract][Full Text] [Related]
13. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. Mitsnefes MM; Kimball TR; Kartal J; Witt SA; Glascock BJ; Khoury PR; Daniels SR J Am Soc Nephrol; 2005 Sep; 16(9):2796-803. PubMed ID: 16049067 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study. Górriz JL; Molina P; Bover J; Barril G; Martín-de Francisco AL; Caravaca F; Hervás J; Piñera C; Escudero V; Molinero LM; Nefrologia; 2013 Jan; 33(1):46-60. PubMed ID: 23364626 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the Prevalence and Severity of Dysregulated Bone Mineral Homeostasis in Nondialyzed Chronic Kidney Disease Patients. Patel DD; Vachhani U; Rajput A; Raghavani P; Parchwani DN; Dholariya S J Lab Physicians; 2022 Jun; 14(2):144-150. PubMed ID: 35982879 [No Abstract] [Full Text] [Related]
16. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609 [TBL] [Abstract][Full Text] [Related]
17. Clinical and metabolic findings in dogs with chronic renal failure fed two diets. Hansen B; DiBartola SP; Chew DJ; Brownie C; Nagode L Am J Vet Res; 1992 Mar; 53(3):326-34. PubMed ID: 1595957 [TBL] [Abstract][Full Text] [Related]
18. Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease. Viaene L; Meijers BK; Vanrenterghem Y; Evenepoel P Am J Nephrol; 2012; 35(5):434-41. PubMed ID: 22538635 [TBL] [Abstract][Full Text] [Related]
19. Serum fibroblast growth factor 23 concentrations in dogs with chronic kidney disease. Dittmer KE; Perera KC; Elder PA Res Vet Sci; 2017 Oct; 114():348-350. PubMed ID: 28667925 [TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]